Evaluating ΔMTV%, ΔDmax%, and %ΔSUVmax of 18F-FDG PET/CT for mid-treatment efficacy and prognosis in diffuse large B-cell lymphoma
The rate of change in metabolic and diffusion parameters on interim PET/CT can predict the prognosis of patients with DLBCL.
Authors
- Yali Cui (ORCID: https://orcid.org/0000-0001-8397-4588)
- Yao Li (ORCID: https://orcid.org/0000-0001-8402-3178)
- Sijin Li (ORCID: https://orcid.org/0000-0003-0361-1248)
- Zhifang Wu (ORCID: https://orcid.org/0000-0002-4122-4786)
- Hongliang Wang (ORCID: https://orcid.org/0000-0003-3225-6417)
- Wenhao Hu
Institutions
- Shanxi Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1007/s12672-025-02126-w
- Citations
- 4
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.89
Funders
- National Natural Science Foundation of China